Core Points - The company is holding its 2024 Annual General Meeting (AGM) to discuss various proposals including financial reports and stock issuance plans [1][12][30] - The company plans to issue A-shares to specific investors, with a total fundraising target of up to 960 million yuan [22][25] - The company reported a net loss of 114.57 million yuan for 2024, leading to a decision not to distribute dividends [12][14] - The company aims to use remaining raised funds to permanently supplement working capital, with a total of 2.2354 million yuan available [14][15] - The company is proposing to authorize the board to issue shares not exceeding 300 million yuan, which is capped at 20% of the net assets as of the end of the previous year [19][20] Meeting Procedures - The AGM will ensure the rights of all shareholders and maintain order during the meeting [2][3] - Shareholders must arrive 20 minutes before the meeting to register and present identification [3][4] - Voting will be conducted through a combination of on-site and online methods, with each share carrying one vote [5][8] Proposals Overview - The AGM will review multiple proposals including the financial budget for 2025, the issuance of A-shares, and the appointment of auditors [9][10][11] - Specific proposals include the authorization for the board to issue shares, the financial budget report, and the profit distribution plan [12][13][18] - The company plans to purchase liability insurance for directors and senior management to enhance risk management [20][21] Financial Performance - The company reported a net profit of -114.57 million yuan for 2024, with a plan to retain earnings for future growth [12][14] - The company’s financial audit for 2024 was conducted by KPMG, with fees remaining unchanged from the previous year [18][19] Future Plans - The company has outlined a three-year shareholder return plan for 2025-2027 [30][31] - The company emphasizes its commitment to innovation and plans to allocate funds towards technology-driven projects [31][32]
微芯生物: 2024年度股东大会会议资料